SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 278.18 |
| Enterprise Value ($M) | 80.32 |
| Book Value ($M) | 185.37 |
| Book Value / Share | 3.53 |
| Price / Book | 1.50 |
| NCAV ($M) | 15.19 |
| NCAV / Share | 0.29 |
| Price / NCAV | 18.31 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.74 |
| Return on Assets (ROA) | -0.35 |
| Return on Equity (ROE) | -0.63 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.42 |
| Current Ratio | 8.42 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 202.49 |
| Assets | 372.67 |
| Liabilities | 187.30 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Perlroth Victor | 10.40 | -13.94 | |
| 13G/A | BlackRock, Inc. | 7.70 | -5.95 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 70,808 | 572,888 | 12.36 | |
| 132,016 | 458,659 | 28.78 | |
| 113,613 | 411,221 | 27.63 | |
| 99,741 | 291,108 | 34.26 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| JANX – Janux Therapeutics, Inc. | KALV – KalVista Pharmaceuticals, Inc. |
| KLTO – Klotho Neurosciences, Inc. | KROS – Keros Therapeutics, Inc. |
| KYMR – Kymera Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io